Lipigon Pharmaceuticals Market Risk Adjusted Performance
| LPGO Stock | | | SEK 0.01 -0.0004 -5.88% |
The Market Risk Adjusted Performance lookup presents technical context for Lipigon Pharmaceuticals AB and related instruments. Data availability can vary by region and feed;
Equity Screeners provides broader screening access. Lipigon Pharmaceuticals has a market cap of 25.81 M, operating margin of -338.33%, ROE of -1.7%.
Correlation Analysis can help frame allocation decisions. The allocation includes a position in Lipigon Pharmaceuticals AB inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in inflation.
Lipigon Pharmaceuticals AB has current Market Risk Adjusted Performance of 10.51.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | 10.51 | |
| ER[a] | = | Expected return on investing in Lipigon Pharmaceuticals |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
Lipigon Pharmaceuticals Market Risk Adjusted Performance Peers Comparison
Lipigon Market Risk Adjusted Performance Relative To Other Indicators
Lipigon Pharmaceuticals AB is currently recognized as the top-ranked stock in market risk adjusted performance category among its top competitors. It is currently under evaluation. in maximum drawdown category among its top competitors reporting about
11.24 of Maximum Drawdown per Market Risk Adjusted Performance. The ratio of Maximum Drawdown to Market Risk Adjusted Performance for Lipigon Pharmaceuticals AB is roughly
11.24 Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.